Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Zimmer Biomet Holdings, Inc. (ZBH) had Cost of Goods Sold of $549.80M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$1.91B
Net Income	$182.00M
Cost of Goods Sold	$549.80M
Gross Profit	$1.36B
Operating Expenses	$1.62B
Operating Income	$292.30M
Non-Operating Income/Expense	$-63.30M
Pre-Tax Income	$229.00M
Normalized Pre-Tax Income	$229.00M
Income after Taxes	$182.50M
Income from Continuous Operations	$182.50M
Consolidated Net Income/Loss	$182.60M
Normalized Income after Taxes	$182.50M
EBIT	$292.30M
EBITDA	$546.70M
Weighted-Average Shares Outstanding (Basic)	198.90M
Weighted-Average Shares Outstanding (Diluted)	199.70M
Earnings per Share (EPS) (Basic)	$0.92
Earnings per Share (EPS) (Diluted)	$0.91
Balance Sheet Financials
Current Assets	$5.59B
Property, Plant, and Equipment	$2.06B
Long-Term Assets	$16.59B
Total Assets	$22.18B
Current Liabilities	$2.29B
Long-Term Debt	$6.58B
Long-Term Liabilities	$7.49B
Total Liabilities	$9.78B
Common Equity	$12.40B
Tangible Shareholders Equity	$-1.05B
Shareholders Equity	$12.40B
Common Shares Outstanding	197.90M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$382.80M
Cash Flow from Investing Activities	$-106.00M
Cash Flow from Financial Activities	$575.40M
Beginning Cash	$525.50M
End Cash	$1.38B
Increase/Decrease in Cash	$859.10M
Stock-Based Compensation	$19.60M
Common Stock Dividends Paid	$-47.80M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.44
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.35
Debt to Equity Ratio	0.58
Gross Margin	71.20%
Operating Margin	15.31%
EBIT Margin	15.31%
EBITDA Margin	--
Pre-Tax Profit Margin	12.00%
Profit Margin	9.53%
Free Cash Flow	$278.50M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.24
Receiveable Turnover	1.25
Days Sales in Receivables	72.29
Return on Equity	1.47%
Return on Tangible Equity	-17.34%
Return on Assets	0.82%
Return on Investments	0.96%
Book Value Per Share	$62.68
Free Cash Flow per Share	$1.39
Operating Cash Flow per Share	$1.92

Data from Zacks Investment Research, Inc.